When engineers design targeted nanoparticles, they often envision a pristine surface decorated with specific keys—such as peptides or antibodies—engineered to unlock matching receptors on target cells. However, the moment a nanoparticle enters a complex biological fluid like blood or gastric juice, this pristine surface vanishes. Instead, it is instantly blanketed by a chaotic swarm of native proteins and lipids.
This spontaneous coating is known as the biomolecular corona (or protein corona). As Wang et al. observe, this layer fundamentally redefines the "biological identity" of the nanomaterial. Cells do not see the underlying engineered particle; they see the corona. Understanding and controlling this interface is one of the most critical challenges in translating nanotechnology from the laboratory to clinical reality.
The Problem: Ligand Masking and the In Vivo Gap
The primary consequence of the biomolecular corona is ligand masking. When serum proteins adsorb non-specifically to the nanoparticle, they physically bury the carefully engineered targeting ligands.
Liao et al. and Liu et al. highlight that this masking creates a severe performance gap between in vitro and in vivo applications. A nanocarrier might successfully bind to a target receptor in a serum-free petri dish, yet fail entirely in a living organism because its targeting keys are covered by a protein shroud. This phenomenon complicates the predictable delivery of nanomedicines to specific sites, such as tumors or atherosclerotic plaques, as noted by Wu et al. and Gao et al.
[ Pristine Nanoparticle ] + [ Serum Proteins ] ---> [ Nanoparticle with Corona ]
(Targeting ligands (Spontaneous (Ligands physically buried;
accessible) adsorption) targeting compromised)
This masking effect is not unique to intravenous injections. In oral drug delivery, the authors of Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems explain that local proteins and lipids in the gastrointestinal tract form a corona that neutralizes the engineered "sticky" or "slippery" surface chemistry of the particles, leading to unpredictable transit behaviors.
Furthermore, simply adding more targeting ligands to force a connection does not solve the problem. Using molecular dynamics simulations, Jimenez‐Cruz et al. demonstrated that over-functionalizing rigid nanostructures (like carbon nanotubes) can cause them to become non-specifically "clamped" to the wrong parts of blood proteins, destroying their selectivity entirely.
The Dynamics of Competitive Adsorption
The corona is not a static or random clump of proteins; it is a highly dynamic, competitive ecosystem. When a particle enters a fluid, hundreds of different protein species compete for space on its surface.
Through all-atom molecular dynamics simulations, Sun et al. showed that this competitive adsorption makes it incredibly difficult to predict how a corona matures over time. The final composition of the corona depends heavily on the nanoparticle's intrinsic properties, such as size, geometry, and surface charge.
Barrow et al. demonstrated that a nanoparticle's surface charge dictates the specific types of proteins it recruits from the surrounding environment. This recruited layer then acts as a biological intermediary that determines how the particle enters a cell. If the wrong proteins win the surface competition, they can trigger toxic cellular aggregation (Šimundić et al.) or signal the immune system to rapidly clear the particles via the reticuloendothelial system. This challenge is so fundamental to biology that even natural extracellular vesicles carry a plasma protein corona that dictates how recipient cells recognize them (Shen et al.).
Strategy 1: Preventing the Corona via Stealth Coatings
To maintain ligand accessibility, researchers have developed surface modifications that prevent proteins from adsorbing in the first place.
Historically, this was achieved via PEGylation—attaching polyethylene glycol chains to the surface. For example, Peters et al. showed that combining surface hydrolysis with PEGylation effectively repels proteins like Bovine Serum Albumin, extending circulation times. However, because PEG can trigger immune responses in some patients, the field has shifted toward alternative "stealth" strategies.
Zwitterionic Surface Functionalization
The most prominent alternative is zwitterionic functionalization. Zwitterionic molecules possess an equal number of positively and negatively charged chemical groups, giving them an overall neutral charge. This unique configuration allows them to bind water molecules tightly via ionic solvation, forming a rigid, highly hydrated physical barrier. Serum proteins cannot displace this water layer easily, meaning they cannot touch or stick to the nanoparticle surface.
Zwitterionic Layer Hydration Shield Serum Protein
+ - + - + ---> H2O H2O H2O H2O ---> [ Bounces ]
- + - + - H2O H2O H2O H2O [ Off ]
Liu et al. note that designing nanocarrier surfaces with zwitterionic or mixed-charge peptide sequences minimizes corona interference, ensuring that targeting ligands remain exposed. As Ren demonstrates, functionalizing nanoprobes with zwitterionic phosphorylcholine drastically reduces non-specific protein adsorption, causing binding rates to drop from over 90% down to less than 2%. This allows the particles to maintain their ultra-small size and move freely through complex biological systems without being sequestered. This hydration strategy effectively prevents opsonization and evades rapid immune clearance (Kang et al.).
Other structural approaches achieve a similar stealth effect. For instance, Xie et al. developed carbon quantum dots that mimic large amino acids, achieving high water solubility and avoiding immune recognition without relying on PEG. Meanwhile, Chen et al. designed diblock polymer brushes that allow researchers to dynamically tune and control protein adsorption by altering environmental pH.
Strategy 2: Pre-Stabilization (Harnessing the Corona)
Instead of fighting protein adsorption, an emerging alternative paradigm seeks to embrace it. If a nanoparticle is inevitably going to be coated in proteins, researchers can choose to define that coating before injection.
Du et al. demonstrated that pre-coating silver nanoparticles with specific serum proteins prior to administration creates a pre-stabilized biological layer. This intentional corona improves biocompatibility, dampens toxic inflammatory responses, and prevents unpredictable interactions with host tissues.
By precisely tuning the physical dimensions and surface chemistry of the underlying material, engineers can deliberately recruit specific, favorable proteins from the host environment to guide cellular uptake and avoid immune clearance (Wang et al.). As Jiang et al. emphasize, optimizing and controlling this protein shell—rather than ignoring it—is a necessary step to ensure consistent therapeutic performance and safety during clinical translation.
Key Foundational Work
Effect of engineered TiO2and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesicles (2013) — contributed 1 concept elements to this direction.
The Selective Interaction between Silica Nanoparticles and Enzymes from Molecular Dynamics Simulations (2014) — contributed 1 concept elements to this direction.
Bio-mimicking of Proline-Rich Motif Applied to Carbon Nanotube Reveals Unexpected Subtleties Underlying Nanoparticle Functionalization (2014) — contributed 1 concept elements to this direction.